Recruitment

Recruitment Status
Completed
Estimated Enrollment
154

Summary

Conditions
Chronic Lymphocytic Leukemia
Type
Interventional
Phase
Phase 3
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Min Age
18
Max Age
90
Gender
Both

Locations

Stockholm, 14186
Stockholm, 14186

Tracking Information

NCT #
NCT01892618
Collaborators
Not Provided
Investigators
  • Principal Investigator: Eva Kimby, Professor Karolinska University Hospital, SE-141 86 Stockholm, Sweden
  • Eva Kimby, Professor Karolinska University Hospital, SE-141 86 Stockholm, Sweden